Safety Alert for IF Electrostatic Therapy Device

According to Food and Drug Administration Philippines, this safety alert involved a device in Philippines that was produced by N/A.

What is this?

Alerts provide important information and recommendations about products. Even though an alert has been issued, it does not necessarily mean a product is considered to be unsafe. Safety Alerts, addressed to health workers and users, may include recalls. They can be written by manufacturers, but also by health officials.

Learn more about the data here
  • Type of Event
    Safety alert
  • Event Number
    2018-259
  • Event Country
  • Event Source
    FDAP
  • Event Source URL
  • Notes / Alerts
    Data from the Philippines is current through 2019. All of the data comes from the Food and Drug Administration Philippines, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Philippines.
  • Extra notes in the data
  • Reason
    Fda advisory no. 2018-259 public health warning against the unapproved and misleading advertisements and promotion of if electrostatic therapy device the food and drug administration (fda) warns the public against the unapproved, false and misleading advertisements and promotion of if electrostatic therapy device monitored from flyer collected from ok dok  at 43 annapolis tower greenhills  san juan. the public is hereby warned that the aforementioned claims were not duly approved by the fda. any health device products should not bear any misleading, deceptive and false claims in their labels and/or any promotional materials that will provide erroneous impression on product’s character and identity. hence, false and misleading advertisement of health devices may harm and cause potential risk to the consumers. on the other hand, the false, deceptive and misleading advertisement of these health devices, constitutes violation of title iii, chapter i of the republic act no. 7394, otherwise known as the consumer act of the philippines of 1992.  for more information and inquiries, please e-mail us at cdrrhr_prsddthis email address is being protected from spambots. you need javascript enabled to view it. . or call us at the center for device regulation, radiation health and research (cdrrhr) hotline (02) 857-1900 local 8301.   attachments: fda advisory no. 2018-259.Pdf.

Device

  • Model / Serial
  • Manufacturer
    N/A

Manufacturer

N/A
  • Source
    FDAP